Trial Profile

A Phase II Clinical Study to Evaluate the Efficacy and Safety of KX-826 Tincture in the Treatment of Adult Male Androgenetic Alopecia (AGA) Patients in China

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 23 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, data from this study was presented at CSD 2023
28 Aug 2023 According to a Kintor Pharmaceutical Limited media release, this study will be presented at EADV 2023.
27 Aug 2022 According to a Kintor Pharmaceutical Limited media release, the leading principal investigators, Professor Jianzhong Zhang of Peking University People's Hospital, presented the positive results of the trial at the 6th Annual Meeting of Chinese Hair Research Society sponsored by the Chinese Society of Dermatology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com